-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Crinetics Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q3 2024.
- Crinetics Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $11M, a 336% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $33.5M, a 269% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.3M, a 167% increase from 2022.
- Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $4.97M, a 8054% increase from 2021.
- Crinetics Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $61K, a 94.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)